Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Chemical structures of AZD1775 and PD0166285. Chemical structures of ...
WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1 ...
Wee1 Kinase Inhibitor AZD1775 Effectively Sensitizes Esophageal Cancer ...
Wee1 inhibitor AZD1775 combined with cisplatin further inhibited growth ...
Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in ...
AZD1775 accelerated S phase progression and mitotic entry. (a) AZD1775 ...
WEE1 Inhibitor AZD1775 Abolishes DNA Replication in SETD2-Deficient ...
Frontiers | Wee1 Inhibitor AZD1775 Effectively Inhibits the Malignant ...
WEE1 Inhibitor AZD1775 Regresses SETD2-Deficient Tumors In Vivo (A ...
Wee1 Inhibitor AZD1775 Combined with Cisplatin Potentiates Anticancer ...
AZD1775 inhibited Wee1/CDC2 signaling and led to G2/M arrest in ...
| AZD1775 inhibits the activities of Wee1 kinase in ESCC cells. (A ...
AZD1775 inhibits WEE1 in human leukemia cells in vivo and enhances the ...
Wee1 Inhibitor AZD1775 Effectively Inhibits the Malignant Phenotypes of ...
(PDF) A regimen combining the Wee1 inhibitor AZD1775 with HDAC ...
WEE1 inhibition induces significant AURKA upregulation in AZD1775 ...
The effects of immunosuppressive cells in the TME on AZD1775 plus IR ...
WEE1 kinase inhibitor AZD1775 induces CDK1 kinase-dependent origin ...
| Inhibition of WEE1 with AZD1775 increased G2/M cell cycle arrest in ...
A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy with Cisplatin and ...
Wee1 Kinase Inhibitor AZD1775 Radiosensitizes Hepatocellular Carcinoma ...
Dual targeting of WEE1 and PLK1 by AZD1775 elicits single agent ...
(PDF) Wee1 Inhibitor AZD1775 Combined with Cisplatin Potentiates ...
A Regimen Combining the Wee1 Inhibitor AZD1775 with HDAC Inhibitors ...
Figure 2 from Phase I Study Evaluating WEE1 Inhibitor AZD1775 As ...
Co-treatment with AZD1775 and olaparib significantly inhibited tumor ...
RMSF of Wee1 kinase when bound to reference inhibitors, AZD1775 and ...
PAXIP1 potentiates the combination of WEE1 inhibitor AZD1775 and ...
Antitumor immune response of AZD1775 is mediated via the... | Download ...
AZD1775 activates tumor immune response by IFN pathway and recruiting T ...
PARP inhibitor olaparib combined with WEE1/PLK1 dual inhibitor AZD1775 ...
AZD1775 Adavosertib AZD1775 靶向药 - 基因医生
AZD1775 inhibits the growth of both early passage patient-derived and ...
A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors ...
A phase 2 study of the WEE1 inhibitor AZD1775 in SETD2 -deficient ...
AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to ...
The combination of AZD1775 and Vorinostat suppresses tumor growth in a ...
AZD1775 and birinapant combination treatment has therapeutic efficacy ...
Cell cycle and pH3 analysis of AZD1775 combined with RT or CHOP ...
Cellular effect of AZD1775 treatment in DLBCL. (A) Representative ...
Adavosertib (AZD-1775) is a Potent Wee1 Inhibitor for Colon Cancer ...
复旦大学周祥团队揭示靶向SLC7A11联合WEE1抑制剂AZD1775诱导铁死亡并抑制肿瘤生长_腾讯新闻
Adavosertib (AZD1775) | Wee1 Inhibitor | MedChemExpress
Treatment with WEE1 inhibitor (AZD1775) in gastric cancer cell lines ...
Adavosertib (AZD1775, MK-1775) | Wee1 Inhibitor | CAS 955365-80-7 ...
(PDF) Mutational status of TP53 defines the efficacy of Wee1 inhibitor ...
A Small-Molecule Inhibitor of WEE1, AZD1775, Synergizes with Olaparib ...
A small molecule inhibitor of WEE1, AZD1775, synergizes with olaparib ...
Augmentation of the therapeutic efficacy of WEE1 kinase inhibitor ...
Multiple defects sensitize p53-deficient head and neck cancer cells to ...
(PDF) Discovery of potential WEE1 inhibitors via hybrid virtual screening
Mutational status of TP53 defines the efficacy of Wee1 inhibitor ...
The AZD1775/Vorinostat regimen is active against primary AML cells ...
Targeting the WEE1 kinase as a molecular targeted therapy for gastric ...
GCN2 is a determinant of the response to WEE1 kinase inhibition in ...
The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor ...
WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy ...
PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 ...
Bromodomain and extraterminal domain inhibition synergizes with WEE1 ...
Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in ...
ODF2L expression correlates with sensitivity to WEE1 inhibition in EOC ...
Targeting WEE1 in tumor-associated dendritic cells potentiates ...
Wee1-AZD1775 complex. a Three hydrogen bonds are shown as green dotted ...
